Clinical significance of antinuclear antibodies, anti-neutrophil cytoplasmic antibodies and anticardiolipin antibodies in heroin abusers

Israel Medical Association Journal

Volumn 4, Issue 11 SUPPL., 2002, Pages 908-910

  Nikolova, Milena ^a   Liubomirova, Mila ^a   Iliev, Andrei ^a   Krasteva, Rumiana ^a   Andreev, Emil ^a   Radenkova, Julia ^a   Minkova, Violina ^a   Djerassi, Regina ^a   Kiperova, Boriana ^a   Vlahov, Iordan D ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Anti neutrophil cytoplasmic antibodies; Anticardiolipin antibodies; Antinuclear antibodies; Antiphospholipid syndrome; Drug induced autoantibodies; Heroin abuse

Indexed keywords

ANTIBODIES; BIOASSAY; BIOPSY; DNA; ELECTROPHORESIS; ENZYMES; IMMUNOLOGY; VIRUSES;

VIRAL MARKERS;

BIOMEDICAL ENGINEERING;

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DIAMORPHINE; DOUBLE STRANDED DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTROPHIL CYTOPLASMIC ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; SINGLE STRANDED DNA;

ACUTE KIDNEY FAILURE; ADDICTION; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BIOPSY; CLINICAL ARTICLE; COMA; CONTROLLED STUDY; COUNTER IMMUNOELECTROPHORESIS; DEEP VEIN THROMBOSIS; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DRUG ABUSE; ENDOCARDITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INTERSTITIAL NEPHRITIS; LABORATORY TEST; MALE;

ADOLESCENT; ADULT; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; COUNTERIMMUNOELECTROPHORESIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS B; HEPATITIS C; HEROIN DEPENDENCE; HUMANS; KIDNEY DISEASES; MALE; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0036842692     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Dalekos GN, Manoussakis MN, Zervou E, Tsianos EV, Moutsopoulos HM. Immunologic and viral markers in the circulation of anti-HIV negative heroin addicts. Eur J Clin Invest 1993;23(4):219-25.
2. Spiera H, Oreskes I, Stimmell B. Rheumatoid factor activity in heroin addicts on methadone maintenance. Ann Rheum Dis 1974;33(2):153-6.
3. Smeenk RJ, Lucassen WA, Swaak TJ. Is anticardiolipin activity a cross-reaction of anti-DNA or a separate entity? Arthritis Rheum 1987;30(6):607-17.
4. Jankovic BD, Horvat J, Djordjijevic D, Ramah A, Fridman V, Spahic O. Brain-associated autoimmune features in heroin addicts: correlation to HIV infection and dementia. Int J Neurosci 1991;58:(1-2):113-26.
5. Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979;38(3):621-8.
6. Savona S, Nardi MA, Lennette ET, Karpatkin S. Thrombocytopenic purpura in narcotics addicts. Ann Intern Med 1985;102(6):737-41.
7. Blanck RR, Ream N, Deegan MJ. Immunoglobulins in heroin users. Am J Epidemiol 1980;111(1):81-6.
8. Wetli CV, Noto TA, Fernandez-Carol A. Immunologic abnormalities in heroin addiction. South Med J 1974;67(2):193-7.
9. Harris EN, Charavi AE, Loizou S, et al. Crossreactivity of antiphospholipid antibodies. J Clin Lab Immunol 1985;16(1):1-6.
10. Colaco CB, Elkon KB. The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross-reactive with autoantibodies to double-stranded DNA. Arthritis Rheum 1985;28(1):67-74.
11. Walker TS, Triplett DA, Javed N, Musgrave K. Evaluation of lupus anticoagulants: antiphospholipid antibodies, endothelium associated immunoglobulin, endothelial prostacyclin secretion, and antigenic protein S levels. Thromb Res 1988;51(3):267-81.
12. Drouvalakis KA, Buchanan RR. Phospholipid specificity of autoimmune and drug induced lupus anticoagulants: association of phosphatidylethanolamine reactivity with thrombosis in autoimmune disease. J Rheumatol 1998;25(2):290-5.
13. Metzer WS, Canoso RT, Newton JE. Anticardiolipin antibodies in a sample of chronic schizophrenics receiving neuroleptic therapy. South Med J 1994;87(2):190-2.
14. Lillicrap DP, Pinto M, Benford K, Ford PM, Ford S. Heterogeneity of laboratory test results for antiphospholipid antibodies in patients treated with chlorpromazine and other phenothiazines. Am J Clin Pathol 1990;93(6):771-5.
15. Merrill JT, Shen C, Gugnani M, Lahita RG, Mongey AB. High prevalence of antiphospholipid antibodies in patients taking procainamide. J Rheumatol 1997;24(6):1083-8.
16. Asherson RA, Zulman J, Hughes GR. Pulmonary thromboembolism associated with procainamide induced lupus syndrome and anticardiolipin antibodies. Ann Rheum Dis 1989;48(3):232-5.
17. Nassberger L. Granulocyte autoantibodies - markers for drug-induced autoimmune adverse effects. Clin Nephrol 1992;38(5):293.
18. Ardiles L, Ramirez P, Moya P, Caorsi I, Mezzano S. Anticardiolipin antibodies in acute poststreptococcal glomerulonephritis and streptococcal impetigo. Nephron 1999;83(1):47-52.
19. Hayem G, Kassis N, Nicaise P, et al. Systemic lupus erythematosus-associated catastrophic antiphospholipid syndrome occurring after typhoid fever: a possible role of Salmonella lipopolysaccharide in the occurrence of diffuse vasculopathy-coagulopathy. Arthritis Rheum 1999;42(5):1056-61.
20. Kolarski V, Petrova D, Todorov A, Slavchev B. Extrahepatic manifestations in hepatitis C virus (HCV) infections. Vutr Boles 1999;31(2-3):11-15
21. Cohen P. Les manifestations extra-hepatiques du virus de l'hepatite C. Presse Med 2000;29(4):209-14.
22. Dalekos GN, Zachou K, Liaskos C. The antiphospholipid syndrome and infection. Curr Rheumatol Rep 2001;3(4):277-85.